FIELD: medicine; pharmacology.
SUBSTANCE: method consists in polymer hydrogel production, containing physiologically active substances, by physiologically active substance immobilisation in cross-linked polymer volume, modified with ovomucoid from duck egg-white; the cross-linked polymer being additionally modified with α-amylase inhibitor from wheat seed; as physiologically active substance heparin or hirudin is used. The cross-linked polymer modified with ovomucoid and α-amylase inhibitor is obtained by chemical modification of polymer with ovomucoid and α-amylase inhibitor mix, in proportion of 0.5 to 15 mg ovomucoid to 1 g swollen cross-linked polymer, and 0.5 to 5.0 mg α-amylase inhibitor to 1 g swollen cross-linked polymer.
EFFECT: hydrogels have anticoagulant activity, are eligible for peroral administration in prevention and treatment for cardiovascular disorders.
2 cl, 20 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR OBTAINING BIOSPECIFIC HEMOSORBENT FOR ISOLATING PROTEINASE | 2018 |
|
RU2681883C1 |
METHOD OF OBTAINING THROMBORESISTANT POLYMER MATERIAL | 2014 |
|
RU2556996C1 |
METHOD OF PREPARING INSULIN-CONTAINING POLYMERIC HYDROGEL | 1994 |
|
RU2066551C1 |
METHOD FOR PRODUCING INSULIN-CONTAINING COMPOSITION | 2020 |
|
RU2752509C1 |
BIOSPECIFIC POLYMER ADSORBENT FOR EXTRACTING PROTEINASE (ITS VERSIONS) | 0 |
|
SU1137388A1 |
METHOD OF OBTAINING BIOSPECIFIC HYDROGEL SORBENT FOR SEPARATION OF PROTEINASES | 2014 |
|
RU2567623C2 |
POLYPEPTIDE COMPOSITION | 1999 |
|
RU2171687C2 |
METHOD OF HEME-COMPATIBLE POLYMER PRODUCING | 1983 |
|
SU1114039A1 |
METHOD OF INSULIN DERIVATIVES PREPARING | 1994 |
|
RU2076733C1 |
METHOD OF PRODUCTION OF CAPTURE PHYSIOLOGICALLY ACTIVE SUBSTANCES | 2007 |
|
RU2329053C1 |
Authors
Dates
2008-12-27—Published
2007-07-20—Filed